FDMT 4D Molecular Therapeutics
4D Molecular Therapeutics earnings company data as of 7:30 PM ET 8/20
History
1 period · newest first · EPS & Rev stacked
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q2 | 13 Aug | EPS | — | -1.04 | — |
| Rev | — | $100.0K | — |
SEC filings
Recent issuer filings from EDGAR · 14 shown · open Filing / Doc on SEC.gov
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 2.02 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 8.01 | Filing Doc | |
| 8-K | 1.01,2.03 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 5.02 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| 8-K | 3.02,9.01 | Filing Doc | |
| 8-K | 2.02,5.02 | Filing Doc | |
| 8-K | 8.01 | Filing Doc |
No filings match this filter.
Consensus estimates · SEC filings remain the official record · not investment advice